StockHealthcare · Biotechnology

$SLN

Silence Therapeutics plc

Price · $SLNvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $SLN in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $SLN in the last 30 days.

Wall Street Analysts Think Silence Therapeutics ( SLN ) Could Surge 556.19%: Read This Before Placing a Bet

The consensus price target hints at a 556.2% upside potential for Silence Therapeutics (SLN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

MAY 21·Zacks Commentary

Wall Street Analysts Believe Silence Therapeutics ( SLN ) Could Rally 590.66%: Here's is How to Trade

The mean of analysts' price targets for Silence Therapeutics (SLN) points to a 590.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

via TradingView

Wall Street Analysts Think Silence Therapeutics ( SLN ) Could Surge 556.19%: Read This Before Placing a Bet

Wall Street Analysts Believe Silence Therapeutics ( SLN ) Could Rally 590.66%: Here's is How to Trade

News on $SLN